Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.

Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.

Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...

Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has ...

An update to the traditional deep brain stimulation device enables adaptive pulses of electricity that help to lessen the symptoms of Parkinson’s disease and inform future research.

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach ...

is the world’s first and only closed-loop brain-responsive neurostimulation system for the disease. The RNS System treats seizures by continuously monitoring brain waves, detecting unusual ...

This stimulation, in turn ... This is the first time a so-called ‘closed loop’ brain implant technology has been shown to work in Parkinson’s patients as they go about their daily lives.

As healthcare providers and patients increasingly recognize the benefits of neurostimulation therapies, the market is set for dynamic growth over the next decade. With the global burden of ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...

New closed-loop system self-adjusts DBS therapy to ... approval of BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI). There is no cure for debilitating ...